drugset / Trial / NCT01390324
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether a fixed-dose combination of naratriptan + naproxen is effective compared each monotherapy for the acute treatment of migraine.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | — |
| Comparator | naratriptan | Small molecule | 2.5 mg | — |